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Colloquy: Scientific, Ethical and Policy Challenges 
for Public Universities Engaging in Stem Cell 
Research* 
A University of Minnesota Perspective on SCNT 
Research: Past Challenges and Strategy for the 
Future 
Sr. Vice President Frank B. Cerra, M.D., Senior Vice 
President for Health Sciences and McKnight Presidential 
Leadership Chair, University of Minnesota 
At the University of Minnesota, we are presently engaging 
in important and enlightening dialogue surrounding issues of 
stem cell research and specifically somatic cell nuclear transfer 
(“SCNT”), also called therapeutic or research cloning.  There is 
no better place for this dialogue than in the halls of a public 
research institution; it is here that we must embrace and 
respect all views around science and the pursuit of knowledge.  
We have a long tradition of doing so, and we continue to do so 
in our discussions of SCNT research. 
At the University of Minnesota, and in public institutions 
of higher learning around the world, it is the faculty who decide 
what research they pursue.  The University as an institution is 
responsible for the creation and fostering of an environment 
that maximally encourages and supports research productivity.  
As such, we work from the following platform with regard to 
 © 2008  Frank B. Cerra, Bryan Dowd & Dan S. Kaufman. 
 * This colloquy is the result of the February 26, 2007 conference 
“Creating Stem Cells by Research Cloning: Scientific, Ethical, Legal and 
Policy Challenges” held at the University of Minnesota, Minneapolis, MN.  
The conference was jointly sponsored by the Consortium on Law and Values in 
Health, Environment & the Life Sciences; the Joint Degree Program in Law, 
Health & the Life Sciences; and the Academic Health Center.  Information 
about the conference, including participant biographies and full video is 
available at http://lifesci.consortium.umn.edu/conferences/scnt.php. 
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research: if the research is in an area of interest of one or more 
faculty, if it is within existing legal and regulatory parameters, 
if the faculty has resources to conduct the research, if the 
University has the facilities and services to support the 
research, and if the research has been approved by the 
appropriate oversight agencies it can be performed at the 
University.  However, the research journey is not a wide open 
road; not for administration nor for the researchers.  It comes 
with responsibility. 
In 2003, the University of Minnesota made a strategic, and 
somewhat political, decision to limit our research portfolio in 
the area of SCNT research.  After careful internal and external 
debate, university policy was adopted that would only allow the 
use of public funding for stem cell research if it was also 
eligible for federal funding.1  Further, we would specifically not 
allow for the creation of embryos for research regardless of 
funding.2  We limited the source of human embryonal stem 
cells to embryos being discarded after in vitro fertilization.3  
Since that time, faculty have come forward interested in the 
pursuing the potential promise of therapeutic cloning as a tool 
for disease therapies.  We are obligated to re-evaluate 
university policy and determine whether in the scientific 
community and in our community at large we believe the 
creation of embryos for the purposes of this research is worth 
the pursuit. 
University researchers also play an important role in their 
field and must adhere to norms of scientific integrity and 
accuracy in reporting of research results.  This point has 
recently hit close to home for us here at the University of 
Minnesota.  In early 2007, accusations were made against a 
well-known faculty member and then Director of the Stem Cell 
Institute that publications regarding adult stem cell findings 
 1. OFFICE OF REGULATORY AFFAIRS, UNIV. OF MINN., CONDUCTING 
RESEARCH WITH HUMAN EMBRYOS OR EMBRYONIC STEM CELLS (2003) (on file 
with the University of Minnesota Policy Librarian), available at 
http://process.umn.edu/groups/ppd/documents/Policy/stemcell_pol.cfm. 
 2. OFFICE OF REGULATORY AFFAIRS, UNIV. OF MINN., PROJECT 
ADMINISTRATION FOR RESEARCH INVOLVING HUMAN EMBRYOS OR EMBRYONIC 
STEM CELL LINES INELIGIBLE FOR FEDERAL/STATE FUNDING (2003) (on file 
with the University of Minnesota Policy Librarian), available at 
http://process.umn.edu/groups/ppd/documents/procedure/stemcell_proc2.cfm. 
 3. Id. 
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contained duplicated data.4  A New Scientist reporter alerted 
Dr. Catherine Verfaillie to errors in her landmark Nature study 
regarding the plasticity of a rare type of adult stem cell.5  A 
university inquiry found that there were duplicated graphs and 
data inconsistencies in describing proteins present on the cell’s 
surface; however the University panel found no evidence of 
scientific misconduct on the part of the research team.6  As 
researchers develop the tools to investigate the science and 
report results back to the public, society must be patient about 
the progression of the scientific process in new areas of 
research and inquiry.  The scientific process has served the 
research community well for many years and will continue to 
evolve as necessary for these developing areas.  In science the 
truth will be told; it is just time that stands between us and the 
understanding of the science. 
Society also plays a hand in the pursuit of new knowledge.  
As a community of ideas we are called to ensure this healthy, 
thorough and fruitful dialogue to advance our understanding of 
the science, the value of its potential, and to weigh the ethical 
and legal arguments of those scientific and research premises. 
The field of medicine will be transformed by the field of 
stem cell science.  Indeed, here in our institution, stem cell 
science serves as one of the primary platforms that enable our 
faculty to advance the cures and therapies in areas of research, 
such as heart disease, diabetes, brain sciences, and so forth.  In 
our lifetime, each of us will be touched by the promise and, if 
all goes well, the real hope of stem cell biology. 
 4. Peter Aldhous & Eugenie Samuel Reich, Fresh Questions on Stem Cell 
Findings, NEW SCIENTIST, Mar. 24, 2007, at 12. 
 5. Yuehua Jiang et al., Pluripotency of Mesenchymal Stem Cells Derived 
from Adult Marrow, 418 NATURE 41 (2002). 
 6. Nicholas Wade, Panel Finds Flawed Data In a Major Stem Cell 
Report, N.Y. TIMES, Feb. 28, 2007, at A15.  Dr. Verfaillie remains a part-time 
faculty member at the University of Minnesota.  She is now with the Catholic 
University of Leuven in Belgium.  Id. 
CERRA F. A UNIVERSITY OF MINNESOTA PERSPECTIVE ON SCNT RESEARCH: PAST CHALLENGES AND 
STRATEGY FOR THE FUTURE. MINN. J.L. SCI. & TECH. 2008;9(1):239-242.  
242 MINN. J.L. SCI. & TECH. [Vol. 9:1 
 
 
*** 
